Wednesday, November 15, 2017 11:20:30 AM
Petitioner: Multicell Immunotherapeutics, Inc.
Respondent: GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc.
Case Number: 3:2017cv06491
Filed: November 8, 2017
Court: California Northern District Court
Office: San Francisco Office
County: XX US, Outside State
Presiding Judge: Elizabeth D. Laporte
Nature of Suit: Other Statutes: Arbitration
Cause of Action: 09:1 U.S. Arbitration Act
Jury Demanded By: None
https://dockets.justia.com/docket/california/candce/3:2017cv06491/319238
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM